| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |